Andrew S. Boyer, Executive Vice President of Amneal Pharmaceuticals ($AMRX), sold nearly $2.9 million in shares through two open market transactions in the past year. His latest sale was on August 20, 2025. These AMRX insider sales rank 2,775th among 11,678 individuals, trailing the average of about $8.6 million over roughly six trades per insider. Boyer recorded no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Class A Common Stock | 38195 | $0.00 | 445,208.0000 | 324,754,000 | 9.38% | 0.01% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | F | Class A Common Stock | 199175 | $13.31 | 407,013.0000 | 324,754,000 | 32.86% | 0.06% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Class A Common Stock | 397554 | $0.00 | 606,188.0000 | 324,754,000 | 190.55% | 0.12% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | F | Class A Common Stock | 12154 | $13.31 | 208,634.0000 | 324,754,000 | 5.50% | 0.00% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Class A Common Stock | 24258 | $0.00 | 220,788.0000 | 324,754,000 | 12.34% | 0.01% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | F | Class A Common Stock | 24897 | $13.31 | 196,530.0000 | 324,754,000 | 11.24% | 0.01% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Class A Common Stock | 49694 | $0.00 | 221,427.0000 | 324,754,000 | 28.94% | 0.02% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | F | Class A Common Stock | 19945 | $13.31 | 171,733.0000 | 324,754,000 | 10.41% | 0.01% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Class A Common Stock | 39252 | $0.00 | 191,678.0000 | 324,754,000 | 25.75% | 0.01% |
| March 4, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Restricted Stock Units | 38195 | $0.00 | 76,389.0000 | 324,754,000 | 33.33% | 0.01% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Performance-Based Restricted Stock Units | 397554 | $0.00 | 0.0000 | 324,754,000 | 100.00% | 0.12% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Restricted Stock Units | 24258 | $0.00 | 72,774.0000 | 324,754,000 | 25.00% | 0.01% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Restricted Stock Units | 49694 | $0.00 | 49,695.0000 | 324,754,000 | 50.00% | 0.02% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Restricted Stock Units | 39252 | $0.00 | 0.0000 | 324,754,000 | 100.00% | 0.01% |
| March 4, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | F | Class A Common Stock | 19136 | $13.30 | 426,072.0000 | 324,754,000 | 4.30% | 0.01% |
| March 2, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | A | Restricted Stock Units | 65359 | $0.00 | 65,359.0000 | 324,754,000 | 9999.99% | 0.02% |
| March 2, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | A | Performance-Based Restricted Stock Units | 65359 | $0.00 | 65,359.0000 | 324,754,000 | 9999.99% | 0.02% |
| Aug. 20, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Stock Option | 175000 | $0.00 | 97,480.0000 | 308,978,000 | 64.22% | 0.06% |
| Aug. 20, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | S | Class A Common Stock | 279244 | $9.38 | 152,426.0000 | 308,978,000 | 64.69% | 0.09% |
| Aug. 20, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Class A Common Stock | 175000 | $2.75 | 431,670.0000 | 308,978,000 | 68.18% | 0.06% |
| Aug. 12, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | S | Class A Common Stock | 33436 | $9.05 | 256,670.0000 | 308,978,000 | 11.53% | 0.01% |
| March 5, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | S | Class A Common Stock | 125000 | $8.89 | 290,106.0000 | 308,978,000 | 30.11% | 0.04% |
| March 4, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | F | Class A Common Stock | 19537 | $8.84 | 415,106.0000 | 308,978,000 | 4.49% | 0.01% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Class A Common Stock | 39251 | $0.00 | 315,555.0000 | 308,978,000 | 14.21% | 0.01% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | F | Class A Common Stock | 20077 | $8.76 | 295,478.0000 | 308,978,000 | 6.36% | 0.01% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Class A Common Stock | 49694 | $0.00 | 345,172.0000 | 308,978,000 | 16.82% | 0.02% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | F | Class A Common Stock | 25419 | $8.76 | 319,753.0000 | 308,978,000 | 7.36% | 0.01% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Class A Common Stock | 157005 | $0.00 | 476,758.0000 | 308,978,000 | 49.10% | 0.05% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | F | Class A Common Stock | 80309 | $8.76 | 396,449.0000 | 308,978,000 | 16.84% | 0.03% |
| March 4, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Class A Common Stock | 38194 | $0.00 | 434,643.0000 | 308,978,000 | 9.63% | 0.01% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Restricted Stock Units | 39251 | $0.00 | 39,252.0000 | 308,978,000 | 50.00% | 0.01% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Restricted Stock Units | 49694 | $0.00 | 99,389.0000 | 308,978,000 | 33.33% | 0.02% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Performance-Based Restricted Stock Units | 157005 | $0.00 | 0.0000 | 308,978,000 | 100.00% | 0.05% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | A | Performance-Based Restricted Stock Units | 194064 | $0.00 | 194,064.0000 | 308,978,000 | 9999.99% | 0.06% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | A | Restricted Stock Units | 97032 | $0.00 | 97,033.0000 | 308,978,000 | 9999.99% | 0.03% |
| March 4, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Restricted Stock Units | 38194 | $0.00 | 114,582.0000 | 308,978,000 | 25.00% | 0.01% |
| March 1, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Class A Common Stock | 31371 | $0.00 | 288,041.0000 | 308,978,000 | 12.22% | 0.01% |
| March 1, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | F | Class A Common Stock | 11737 | $8.67 | 276,304.0000 | 308,978,000 | 4.07% | 0.00% |
| March 1, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Restricted Stock Units | 31371 | $0.00 | 0.0000 | 308,978,000 | 100.00% | 0.01% |
| Aug. 15, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | S | Class A Common Stock | 40225 | $7.85 | 256,670.0000 | 176,136,000 | 13.55% | 0.02% |
| Aug. 14, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | S | Class A Common Stock | 22486 | $7.81 | 296,895.0000 | 176,136,000 | 7.04% | 0.01% |
| March 3, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | F | Class A Common Stock | 19665 | $5.47 | 294,584.0000 | 176,136,000 | 6.26% | 0.01% |
| March 3, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Class A Common Stock | 49694 | $0.00 | 344,278.0000 | 176,136,000 | 16.87% | 0.03% |
| March 3, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | F | Class A Common Stock | 24897 | $5.47 | 319,381.0000 | 176,136,000 | 7.23% | 0.01% |
| March 1, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Restricted Stock Units | 31371 | $0.00 | 31,371.0000 | 176,136,000 | 50.00% | 0.02% |
| March 3, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Restricted Stock Units | 39251 | $0.00 | 78,503.0000 | 176,136,000 | 33.33% | 0.02% |
| March 4, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | A | Restricted Stock Units | 152778 | $0.00 | 152,778.0000 | 176,136,000 | 9999.99% | 0.09% |
| March 3, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Restricted Stock Units | 49694 | $0.00 | 149,083.0000 | 176,136,000 | 25.00% | 0.03% |
| March 4, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | A | Performance-Based Restricted Stock Units | 305556 | $0.00 | 305,556.0000 | 176,136,000 | 9999.99% | 0.17% |
| March 1, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Class A Common Stock | 31371 | $0.00 | 291,217.0000 | 176,136,000 | 12.07% | 0.02% |
| March 1, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | F | Class A Common Stock | 16219 | $5.47 | 274,998.0000 | 176,136,000 | 5.57% | 0.01% |
| March 3, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Class A Common Stock | 39251 | $0.00 | 314,249.0000 | 176,136,000 | 14.27% | 0.02% |
| Feb. 27, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Restricted Stock Units | 31663 | $0.00 | 0.0000 | 176,136,000 | 100.00% | 0.02% |
| Feb. 27, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | F | Class A Common Stock | 16556 | $5.71 | 259,846.0000 | 176,136,000 | 5.99% | 0.01% |
| Feb. 27, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Class A Common Stock | 31663 | $0.00 | 276,402.0000 | 176,136,000 | 12.94% | 0.02% |
| Aug. 11, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | S | Class A Common Stock | 29302 | $4.13 | 244,739.0000 | 150,944,000 | 10.69% | 0.02% |
| June 30, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Class A Common Stock | 23095 | $0.00 | 285,612.0000 | 150,944,000 | 8.80% | 0.02% |
| June 30, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | F | Class A Common Stock | 11571 | $3.10 | 274,041.0000 | 150,944,000 | 4.05% | 0.01% |
| June 30, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Restricted Stock Units | 23095 | $0.00 | 0.0000 | 150,944,000 | 100.00% | 0.02% |
| March 3, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | A | Restricted Stock Units | 198777 | $0.00 | 198,777.0000 | 150,944,000 | 9999.99% | 0.13% |
| March 3, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Restricted Stock Units | 39251 | $0.00 | 117,754.0000 | 150,944,000 | 25.00% | 0.03% |
| March 3, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | F | Class A Common Stock | 19685 | $1.92 | 262,517.0000 | 150,944,000 | 6.98% | 0.01% |
| March 3, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Class A Common Stock | 39251 | $0.00 | 282,202.0000 | 150,944,000 | 16.16% | 0.03% |
| March 3, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | A | Performance-Based Restricted Stock Units | 397554 | $0.00 | 397,554.0000 | 150,944,000 | 9999.99% | 0.26% |
| March 1, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Restricted Stock Units | 12346 | $0.00 | 0.0000 | 150,944,000 | 100.00% | 0.01% |
| March 1, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Restricted Stock Units | 31371 | $0.00 | 62,742.0000 | 150,944,000 | 33.33% | 0.02% |
| March 1, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | F | Class A Common Stock | 16121 | $2.09 | 242,951.0000 | 150,944,000 | 6.22% | 0.01% |
| March 1, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Class A Common Stock | 31371 | $0.00 | 259,072.0000 | 150,944,000 | 13.78% | 0.02% |
| March 1, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | F | Class A Common Stock | 6846 | $2.09 | 227,701.0000 | 150,944,000 | 2.92% | 0.00% |
| March 1, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Class A Common Stock | 12346 | $0.00 | 234,547.0000 | 150,944,000 | 5.56% | 0.01% |
| Feb. 27, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | F | Class A Common Stock | 17557 | $2.16 | 222,201.0000 | 150,944,000 | 7.32% | 0.01% |
| Feb. 27, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Class A Common Stock | 31662 | $0.00 | 239,758.0000 | 150,944,000 | 15.22% | 0.02% |
| Feb. 27, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | BOYER ANDREW S | Executive Vice President | M | Restricted Stock Units | 31662 | $0.00 | 31,663.0000 | 150,944,000 | 50.00% | 0.02% |